BR PHARM, a bio-pharmaceutical company specializing in regenerative medicine, bases its operations on PDRN (polydeoxyribonucleotide) technologies. This raw material is sourced from trout, as its DNA is 95% compatible with human DNA. The company operates vertically integrated fish farming units to ensure the purity of the raw material and oversees the entire production process up to the final product.

It boasts an advanced, state-of-the-art molecule unparalleled in the market, offering exceptional benefits for skin repair and regeneration.